3MA	3-methyladenine
ADT	androgen deprivation therapy
ANOVA	analysis of variance
CI	pan-caspase inhibitor
CRPC	castration-resistant prostate cancer
DCFH2-DA	2′,7′-Dichlorodihydrofluorescein diacetate
DMEM	Dulbecco’s modified Eagle’s medium
DMSO	dimethyl sulfoxide
DR-P27	9-epipolygodial
ECM	extracellular matrix
IAP	inhibitors of apoptosis
MPCCs	micropatterned co-cultures
MTT	3–4,5-dimethylthiazol-2-yl,2,5-diphenyl tetrazolium bromide
NAC	N-acetyl cysteine
NEC	necrostatin-1
OSCC	oral squamous cell carcinoma
PCa	prostate cancer
PG	polygodial
PI	propidium Iodide
PSA	prostate-specific antigen
ROS	reactive oxygen species
TBST	tris-buffered saline tween